Amanote Research
Register
Sign In
New Alternatives in the N.H.S. II. What Advances in Treatment Can We Afford? Criteria for Introducing Technical Advance.
BMJ
doi 10.1136/bmj.4.5940.327
Full Text
Open PDF
Abstract
Available in
full text
Date
November 9, 1974
Authors
P Rhodes
Publisher
BMJ
Related search
New Advances in the N.H.S. II. What Advances in Treatment Can We Afford? What Information Do Doctors Need?
BMJ
Can We Afford Open-Ended ICU Care? Yes We Can, but ...
Critical Care
Critical Care
Intensive Care Medicine
Can We Afford Screening for Neural Tube Defects?
BMJ
Remedies for the Obesity Epidemic: Can We Afford Them? Do We Want Them?
Online Journal of Health Ethics
Biomarkers Predicting Antidepressant Treatment Response: How Can We Advance the Field?
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
We Have a New Treatment, but You Can't Afford It
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
News From ASH 2018—how Can We Afford Innovation in the Future?
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Antimicrobial Stewardship - Can We Afford to Do Without It?
British Journal of Clinical Pharmacology
Pharmacology
Can We Afford to Neglect Forest Insect Outbreaks
Forestry Chronicle
Forestry